MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1492.72%
Quick Ratio
1492.72%
Cash Ratio
339.72%
Debt to Asset Ratio
6.82%
Unit: Thousand (K) dollars
Assets Breakdown
    • Investments
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses and other curre...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
107,250
55,085
50,106
220,942
Investments
353,955
256,210
148,799
-
Prepaid expenses and other current assets
10,046
7,222
2,455
2,042
Total current assets
471,251
318,517
201,360
222,984
Property and equipment, net
144
157
176
147
Operating lease right-of-use asset
649
690
740
777
Other assets
69
69
174
60
Total assets
472,113
319,433
202,450
223,968
Accounts payable
6,579
3,979
1,350
7,586
Accrued expenses and other current liabilities
14,922
14,852
14,012
8,091
Related party accrued expenses and other current liabilities
299
794
2,048
2,380
Warrant liability, related party
9,770
2,667
4,947
3,563
Total current liabilities
31,570
22,292
22,357
21,620
Convertible notes payable
-
-
0
-
Long-term lease liability
628
679
747
792
Total liabilities
32,198
22,971
23,104
22,412
Series a non-voting convertible preferred stock, 0.0001 par value 12,622 shares authorized as of both june 30, 2026 and december 31, 2025, 12,622 shares issued and outstanding as of both june 30, 2026 and december 31, 2025
2
2
2
-
Common stock, 0.0001 par value 300,000,000 shares authorized as of june 30, 2026 and december 31, 2025, respectively 63,556,065 and 49,316,287 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
6
5
3
3
Additional paid-in capital
711,089
511,554
321,769
318,857
Accumulated other comprehensive (loss) income
-660
-342
29
-24
Accumulated deficit
-270,522
-214,757
-142,457
-117,282
Total stockholders' equity
439,915
296,462
179,346
201,556
Total liabilities and stockholders' equity
472,113
319,433
202,450
223,968
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Investments$353,955K Cash and cashequivalents$107,250K (-51.46%↓ Y/Y)Prepaid expenses andother current assets$10,046K (391.97%↑ Y/Y)Total current assets$471,251K (111.34%↑ Y/Y)Operating leaseright-of-use asset$649K (-16.47%↓ Y/Y)Property and equipment,net$144K (-2.04%↓ Y/Y)Other assets$69K (15.00%↑ Y/Y)Total assets$472,113K (110.79%↑ Y/Y)Total liabilities andstockholders' equity$472,113K (110.79%↑ Y/Y)Total stockholders'equity$439,915K (118.26%↑ Y/Y)Total liabilities$32,198K (43.66%↑ Y/Y)Accumulated deficit-$270,522K (-130.66%↓ Y/Y)Accumulated othercomprehensive (loss) income-$660K (-2650.00%↓ Y/Y)Additional paid-in capital$711,089K (123.01%↑ Y/Y)Total currentliabilities$31,570K (46.02%↑ Y/Y)Long-term lease liability$628K (-20.71%↓ Y/Y)Common stock, 0.0001par value...$6K (100.00%↑ Y/Y)Series a non-votingconvertible preferred...$2K Accrued expenses andother current...$14,922K (84.43%↑ Y/Y)Warrant liability,related party$9,770K (174.21%↑ Y/Y)Accounts payable$6,579K (-13.27%↓ Y/Y)Related party accruedexpenses and other...$299K (-87.44%↓ Y/Y)

Jade Biosciences, Inc. (JBIO)

Jade Biosciences, Inc. (JBIO)